Anatomically discrete functional effects of adenoviral clostridial light chain gene-based synaptic inhibition in the midbrain

Gene Therapy

Volumn 13, Issue 12, 2006, Pages 942-952

  Zhao, Z ^a   Krishnaney, A ^b   Teng, Q ^b   Yang, J ^b   Garrity Moses, M ^b   Liu, J K ^b   Venkiteswaran, K ^b   Subramanian, T ^b   Davis, M ^a   Boulis, N M ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acoustic startle; Brainstem; Fear; Freezing; Locomotion; Synaptobrevin; Tetanus Toxin

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; SYNAPTOBREVIN; TETANUS TOXIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN REGION; CLOSTRIDIA; CONTROLLED STUDY; GENE EXPRESSION; GENETIC CODE; IMMUNOHISTOCHEMISTRY; LIGHT CHAIN; LOCOMOTION; MALE; MESENCEPHALON; NEUROANATOMY; NEUROMODULATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; STARTLE REFLEX; SUPERIOR COLLICULUS; SYNAPSE VESICLE; SYNAPTIC INHIBITION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; FEAR; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; MALE; MESENCEPHALON; METALLOENDOPEPTIDASES; MODELS, ANIMAL; R-SNARE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REFLEX; SYNAPTIC VESICLES; TETANUS TOXIN;

EID: 33744800298     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302733     Document Type: Article

References (18)

1. Gildenberg P. The history of stereotactic and functional neurosurgery. In: Gildenberg P, Tasker R (eds). Textbook of Stereotactic and Functional Neurosurgery. McGraw-Hill: New York, 1998, pp 5-20.
2. Mogilner A, Rezai A. Brain stimulation: History, current clinical application, and future prospects. Acta Neurochir 2003; 87: 115-120.
3. Noordmans A, Song D, Noordsmans C, Garrity-Moses M, During M, Fitzsimmons H et al. Adeno-associated viral glutamate decarboxylase expression in the lateral nucleus of the rat hypothalamus reduces feeding behavior. Gene Therapy 2004; 11: 797-804.
4. Luo J, Kaplitt M, Fitzsimmons H, Zuzga D, Liu Y, Oshinsky M et al. Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science 2002; 298: 425-429.
5. During M, Kaplitt M, Stern M, Eidelberg D. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. Hum Gene Ther 2001; 12: 1589-1591.
6. Teng Q, Tanase D, Liu J, Garrity-Moses M, Baker K, Boulis N. Adenoviral clostridial light chain gene-based synaptic inhibition through synaptobrevin elimination. Gene Therapy 2005; 12: 108-119.
7. Meloni E, Davis M. GABA in the deep layers of the superior colliculus/ mesencephalic reticular formation mediates the enhancement of startle by the dopamine D1 receptor agonist SKF 82958 in rats. J Neurosci 2000; 20: 5374-5381.
8. Meloni E, Davis M. Muscimol in the deep layers of the superior colliculus/mesencephalic reticular formation blocks expression but not acquisition of fear-potentiated startle in rats. Behav Neurosci 1999; 113: 1152-1160.
9. Zhou Z, Davis M. Fear-potentiated startle in rats is mediated by neurons in the deep layers of the superior colliculus/deep mesencephalic nucleus of the rostral midbrain through the glutamate non-NMDA receptors. J Neurosci 2004; 24: 10326-10334.
10. Thomas C, Schiedner G, Kochanek S, Castro M, Lowenstein P. Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: Toward realistic long-term neurological gene therapy for chronic diseases. Proc Natl Acad Sci USA 2000; 97: 7482-7487.
11. Boulis N, Bhatia V, Brindle T, Holman H, Krauss D, Blaivis M et al. Adenoviral nerve growth factor and β-galactosidase transfer to spinal cord: A behavioral and histological analysis. J Neurosurg 1999; 90: 99-108.
12. Niemann H. Molecular biology of clostridial neurotoxins. In: Alouf JE, Freer JH (eds). Sourcebook of Bacterial Protein Toxins. Academic Press: London, 1991, pp 303-348.
13. Rossetto O, Seveso M, Caccin P, Schiavo G, Montecucco C. Tetanus and botulinum neurotoxins: Turning bad guys into good by research. Toxicon 2001; 39: 27-41.
14. Humeau Y, Doussau F, Grant N, Poulain B. How botulinum and tetanus neurotoxins block neurotransmitter release. Biochimie 2000; 82: 427-446.
15. Schiavo G, Benfenati F, Poulain B, Rossetto O, Polverino de Laureto P, DasGupta B et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992; 359: 832-835.
16. Brooks V, Curtis D, Eccles J. Mode of action of tetanus toxin. Nature 1955; 175: 120-121.
17. Benecke R, Takano K, Schmidt J, Henatsch H. Tetanus toxin induced actions on spinal Renshaw cells in Ia-inhibitory interneurones during development of local tetanus in the cat. Exp Brain Res 1977; 27: 271-286.
18. Aoki K, Barker C, Danthinne X, Imperiale M, Nabel G. Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro. Mol Med 1999; 5: 224-231.